HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luqi Peng Selected Research

Lymphocyte Antigen 96

1/2022Pan-Cancer Analysis of the Characteristics of LY96 in Prognosis and Immunotherapy Across Human Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luqi Peng Research Topics

Disease

1Neoplasms (Cancer)
01/2022
1Carcinogenesis
01/2022

Drug/Important Bio-Agent (IBA)

1Lymphocyte Antigen 96IBA
01/2022

Therapy/Procedure

1Immunotherapy
01/2022
1Therapeutics
01/2022